Lyra Capital

Active

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Oct 7, 2024	Kailera Therapeutics	$400.0M Series A	Gotham Makker, Michael Gladstone, Atlas Venture, Bain Capital Life Sciences, RTW Investments	—
Jun 30, 2021	ArriVent Biopharma	$150.0M Series A	Hillhouse Capital Group	Lilly Asia Ventures, Octagon Capital, OrbiMed, Zoo Capital

Total Raised

N/A

Valuation

N/A